Annual Operating Expenses
$22.90 M
+$3.66 M+19.04%
December 31, 2023
Summary
- As of February 7, 2025, NVCT annual total operating expenses is $22.90 million, with the most recent change of +$3.66 million (+19.04%) on December 31, 2023.
- NVCT annual operating expenses is now at all-time high.
Performance
NVCT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$4.36 M
-$284.00 K-6.12%
September 30, 2024
Summary
- As of February 7, 2025, NVCT quarterly total operating expenses is $4.36 million, with the most recent change of -$284.00 thousand (-6.12%) on September 30, 2024.
- Over the past year, NVCT quarterly operating expenses has dropped by -$1.80 million (-29.21%).
- NVCT quarterly operating expenses is now -36.51% below its all-time high of $6.87 million, reached on December 31, 2023.
Performance
NVCT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NVCT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.0% | -29.2% |
| 3 y3 years | - | -29.2% |
| 5 y5 years | - | -29.2% |
NVCT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +77.6% | -36.5% | +92.5% |
| 5 y | 5-year | at high | +77.6% | -36.5% | >+9999.0% |
| alltime | all time | at high | +77.6% | -36.5% | >+9999.0% |
Nuvectis Pharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.36 M(-6.1%) |
| Jun 2024 | - | $4.64 M(+5.6%) |
| Mar 2024 | - | $4.40 M(-36.0%) |
| Dec 2023 | $22.90 M(+19.0%) | $6.87 M(+11.5%) |
| Sep 2023 | - | $6.16 M(+6.7%) |
| Jun 2023 | - | $5.77 M(+40.7%) |
| Mar 2023 | - | $4.10 M(-39.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $19.23 M(+49.2%) | $6.78 M(+14.1%) |
| Sep 2022 | - | $5.94 M(+66.2%) |
| Jun 2022 | - | $3.57 M(+21.3%) |
| Mar 2022 | - | $2.94 M(+30.0%) |
| Dec 2021 | $12.89 M | $2.27 M(-51.5%) |
| Sep 2021 | - | $4.67 M(-21.4%) |
| Jun 2021 | - | $5.94 M(>+9900.0%) |
| Mar 2021 | - | $23.00 K |
FAQ
- What is Nuvectis Pharma annual total operating expenses?
- What is the all time high annual operating expenses for Nuvectis Pharma?
- What is Nuvectis Pharma annual operating expenses year-on-year change?
- What is Nuvectis Pharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly operating expenses year-on-year change?
What is Nuvectis Pharma annual total operating expenses?
The current annual operating expenses of NVCT is $22.90 M
What is the all time high annual operating expenses for Nuvectis Pharma?
Nuvectis Pharma all-time high annual total operating expenses is $22.90 M
What is Nuvectis Pharma annual operating expenses year-on-year change?
Over the past year, NVCT annual total operating expenses has changed by +$3.66 M (+19.04%)
What is Nuvectis Pharma quarterly total operating expenses?
The current quarterly operating expenses of NVCT is $4.36 M
What is the all time high quarterly operating expenses for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly total operating expenses is $6.87 M
What is Nuvectis Pharma quarterly operating expenses year-on-year change?
Over the past year, NVCT quarterly total operating expenses has changed by -$1.80 M (-29.21%)